Condition (MeSH)
Adenocarcinoma, Sebaceous
ClinicalTrials.gov lists 3 trials for Adenocarcinoma, Sebaceous or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Adenocarcinoma, Sebaceous itself; the rest are tagged with a narrower condition beneath it.
When did Adenocarcinoma, Sebaceous trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2023 | 1 |
| 2020 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Adenocarcinoma, Sebaceous trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Not applicable | 1 |
How many Adenocarcinoma, Sebaceous trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Adenocarcinoma, Sebaceous? (11)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease. | Ophthalmic plastic and reconstructive surgery | 2023 | Yes |
| Management of recurrent sebaceous gland carcinoma. | Eye (London, England) | 2020 | Yes |
| Sebaceous carcinoma: evidence-based clinical practice guidelines. | The Lancet. Oncology | 2019 | Yes |
| Current review of sebaceous cell carcinoma. | Current opinion in ophthalmology | 2018 | Yes |
| Sebaceous Carcinoma of the Eyelid. | Cancer control : journal of the Moffitt Cancer Center | 2016 | Yes |
Showing 5 of 11 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.